Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
726 Multiple Sclerosis
clinical trials

Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Bronx, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Burbank, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cullman, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Durham, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Edina, MN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Jackson, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Kansas City, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Kingston, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Naples, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Overland Park, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Pomona, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Somerset, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Southfield, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Springfield, OR
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Temecula, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Waldorf, MD
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Washington DC,
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Weston, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis
Status: Enrolling
Updated: 5/5/2014
University of South Florida, Frank and Carol Morsani Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Impact of CRISP on Self-Efficacy, Loneliness, and Depression
Status: Enrolling
Updated: 9/16/2014
NYU MS Center
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Adherence in Pediatric Multiple Sclerosis
Status: Enrolling
Updated: 2/5/2015
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
iConquerMS™ - A Patient-Powered Research Network for Multiple Sclerosis
Status: Enrolling
Updated: 1/13/2018
Accelerated Cure Project
mi
from
Waltham, MA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Cognitive and Emotion Regulation Training in MS
Status: Enrolling
Updated: 3/17/2016
Department of Psychology, The Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Patchogue, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Stamford, CT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/11/2016
Buffalo Neuroimaging Analysis Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Online Program to Reduce Depression in MS
Status: Enrolling
Updated: 12/31/1969
Penn State University
mi
from
State College, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Holy Name Hospital
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Territory Neurology & Research Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
MS Center of Vero Beach
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Abington Neurological Associates
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Neurology, Other Clinical Trial
From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical Findings
Status: Enrolling
Updated: 4/1/2018
Lakeshore Foundation
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Suncoast Neuroscience Associates Inc
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/12/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Lipoic Acid for Progressive Multiple Sclerosis (MS)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Lipoic Acid for Progressive Multiple Sclerosis (MS)
Status: Enrolling, Phase II
Updated: 12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Neurology, Other Clinical Trial
MitoQ for Fatigue in Multiple Sclerosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Exercise and Learning and Memory in Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Healthy Volunteer Clinical Trial
MS PATHS Normative Sub-Study
Status: Enrolling, Phase
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Comparative Effectiveness Study Telerehab Versus Conventional
Status: Enrolling
Updated: 12/31/1969
University of Georgia
mi
from
Athens, GA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Comparative Effectiveness Study Telerehab Versus Conventional
Status: Enrolling
Updated: 12/31/1969
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Comparative Effectiveness Study Telerehab Versus Conventional
Status: Enrolling
Updated: 12/31/1969
University of North Carolina
mi
from
Raleigh, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects
Status: Enrolling, Phase IV
Updated: 2/5/2018
Holy Name Medical Center
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus - Department of Neurology
mi
from
Aurora, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MS
Status: Enrolling
Updated: 12/31/1969
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Basalt, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
My MS Toolkit: a Symptom Self-management Program for Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 3/10/2009
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Other Clinical Trial
Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
Status: Enrolling, Phase II, III
Updated: 8/27/2009
USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Other Clinical Trial
Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
Status: Enrolling, Phase II, III
Updated: 8/27/2009
MS Hub
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Genes and Environment in Multiple Sclerosis
Status: Enrolling
Updated: 1/26/2016
Emily Owen
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 11/9/2012
XenoPort Clinical Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 11/9/2012
XenoPort Clinical Site
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 11/9/2012
XenoPort Clinical Site
mi
from
Lake Barrington, IL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 11/9/2012
XenoPort Clinical Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Amherst, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Arlington, VA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Basalt, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Johnson City, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Jupiter, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lake Success, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Livingston, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
319, Novartis Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Newport News, VA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Provo, UT
Click here to add this to my saved trials
1 2 3 4 5 6 7